The FDA Is Trying to Figure out How to Regulate Smart Pills
Newly-proposed guidelines say sensor-equipped pills are devices or pharmaceuticals but not both.
Take a Byte
As these devices become increasingly common in the lab, the U.S. Food and Drug Administration — that’s the regulatory body responsible for testing and vetting pharmaceuticals and medical devices — is left figuring out how to deal with the weird new tech.
To make sense of the emerging new field of treatments, the FDA released a draft of newly-proposed guidelines for how developers can get smart pills approved.
The people behind pills with electronic components generally prefer to submit to multiple approval processes, in order to let regulators approve the the pill and electronic components separately. But the new guidelines would require scientists to choose the single most relevant category and stick with it throughout the process.
The reason that developers prefer to break things up piece by piece is because the regulatory process for medical devices may be better suited for the unique challenges of the electronic components of smart pills.
Treating the whole package as one would a typical pharmaceutical may mean holding certain aspects of the treatment to different degrees of rigor than others, MobiHealthNews reports.
READ MORE: FDA’s new draft guidance could hinder applications for digital combination products [MobiHealthNews]
More on edible tech: An Edible Controller Moves Gaming From the Screen to Your Gut
As a Futurism reader, we invite you join the Singularity Global Community, our parent company’s forum to discuss futuristic science & technology with like-minded people from all over the world. It’s free to join, sign up now!